bluebird bio, Inc.·4

Feb 3, 4:05 PM ET

Obenshain Andrew 4

4 · bluebird bio, Inc. · Filed Feb 3, 2023

Insider Transaction Report

Form 4
Period: 2023-02-01
Obenshain Andrew
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2023-02-01$6.38/sh1,420$9,060241,270 total
Footnotes (1)
  • [F1]Shares were withheld to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT